Psychological interventions for positive symptoms in schizophrenia: Protocol for a network meta-Analysis of randomised controlled trials

BMJ Open

Volumn 8, Issue 3, 2018, Pages

  Bighelli, Irene ^a   Salanti, Georgia ^b   Reitmeir, Cornelia ^a   Wallis, Sofia ^a   Barbui, Corrado ^c   Furukawa, Toshi A ^d   Leucht, Stefan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF VERONA   (Italy)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

adult psychiatry; network meta Analysis; psychological interventions; psychotherapy

Indexed keywords

ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CALGARY DEPRESSION SCALE; DEPRESSION; HAMILTON DEPRESSION RATING SCALE; HUMAN; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PSYCHOTHERAPY; QUALITY OF LIFE; SCALES FOR ASSESSMENT OF POSITIVE SYMPTOMS; SCHIZOPHRENIA; SCHIZOPHRENIA ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; THERAPY EFFECT; COGNITIVE THERAPY; COUNSELING; GROUP THERAPY; META ANALYSIS; NETWORK META-ANALYSIS; PATIENT ATTITUDE; PROCEDURES; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

COGNITIVE THERAPY; COUNSELING; HUMANS; NETWORK META-ANALYSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHOTHERAPY, GROUP; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA;

EID: 85044180977     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-019280     Document Type: Article

References (62)

1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.
2. Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multipletreatments meta-Analysis. Lancet 2013;382:951-62.
3. National Collaborating Centre for Mental Health. Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (Clinical Guideline CG82). London 2009.
4. Buchanan RW, Kreyenbuhl J, Kelly DL, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010;36:71-93.
5. Pinquart M, Oslejsek B, Teubert D. Efficacy of systemic therapy on adults with mental disorders: A meta-Analysis. Psychother Res 2016;26:241-57.
6. Ruddy R, Milnes D. Art therapy for schizophrenia or schizophrenialike illnesses. Cochrane Database Syst Rev 2005;4:CD003728.
7. Jones C, Hacker D, Cormac I, et al. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 2012;4:CD008712.
8. Lutgens D, Gariepy G, Malla A. Psychological and psychosocial interventions for negative symptoms in psychosis: systematic review and meta-Analysis. Br J Psychiatry 2017;210:324-32.
9. Zimmermann G, Favrod J, Trieu VH, et al. The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: A meta-Analysis. Schizophr Res 2005;77:1-9.
10. Turner DT, van der Gaag M, Karyotaki E, et al. Psychological interventions for psychosis: A meta-Analysis of comparative outcome studies. Am J Psychiatry 2014;171:523-38.
11. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-Analyses of health care interventions: checklist and explanations. Ann Intern Med 2015;162:777-84.
12. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-Analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;349:g7647.
13. Egger M, Zellweger-Zähner T, Schneider M, et al. Language bias in randomised controlled trials published in English and German. Lancet 1997;350:326-9.
14. Wu T, Li Y, Liu G, Bian Z, Li J, et al. eds. Investigation of authenticity of 'claimed' randomized controlled trials (RCTs) and quality assessment of RCT reports published in China, 2006.
15. Woodhead M. 80% of China's clinical trial data are fraudulent, investigation finds. BMJ 2016;355:i5396.
16. Carpenter WT, Buchanan RW. Schizophrenia. N Engl J Med 1994;330:681-90.
17. Adams CE, Coutinho E, Davis JM, et al; The cochrane library. Chichester, UK: John Wiley & Sons Ltd, 2011.
18. Leucht S, Leucht C, Huhn M, et al. Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, bayesian meta-Analysis, and meta-regression of efficacy predictors. Am J Psychiatry 2017;174:927-42.
19. Zhu Y, Li C, Huhn M, et al. How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-Analysis. Eur Neuropsychopharmacol 2017;27:835-44.
20. Furukawa TA, Noma H, Caldwell DM, et al. Waiting list may be a nocebo condition in psychotherapy trials: A contribution from network meta-Analysis. Acta Psychiatr Scand 2014;130:181-92.
21. Marshall M, Lockwood A, Bradley C, et al. Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia. Br J Psychiatry 2000;176:249-52.
22. Vaughan B, Goldstein MH, Alikakos M, et al. Frequency of reporting of adverse events in randomized controlled trials of psychotherapy vs. psychopharmacotherapy. Compr Psychiatry 2014;55:849-55.
23. Linden M, Schermuly-Haupt ML, Definition S-HM-L. Definition, assessment and rate of psychotherapy side effects. World Psychiatry 2014;13:306-9.
24. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-Treatment metaanalysis: An overview and tutorial. J Clin Epidemiol 2011;64:163-71.
25. Furukawa TA, Barbui C, Cipriani A, et al. Imputing missing standard deviations in meta-Analyses can provide accurate results. J Clin Epidemiol 2006;59:7-10.
26. Higgins JPT. Cochrane handbook for systematic reviews of interventions. Version 5.1.0, 2011. (accessed Mar 2011).
27. Higgins JPT, Altman DG, Sterne JAC. et alAssessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, . Cochrane handbook for systematic reviews of interventions version 5.2.0, 2017. (accessed Jun 2017).
28. Dragioti E, Dimoliatis I, Evangelou E. Disclosure of researcher allegiance in meta-Analyses and randomised controlled trials of psychotherapy: A systematic appraisal. BMJ Open 2015;5:e007206.
29. Lieb K, von der Osten-Sacken J, Stoffers-Winterling J, et al. Conflicts of interest and spin in reviews of psychological therapies: A systematic review. BMJ Open 2016;6:e010606.
30. Munder T, Brötsch O, Leonhart R, et al. Researcher allegiance in psychotherapy outcome research: An overview of reviews. Clin Psychol Rev 2013;33:501-11.
31. Furukawa TA, Salanti G, Atkinson LZ, et al. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-Analysis. BMJ Open 2016;6:e010919.
32. Turner RM, Davey J, Clarke MJ, et al. Predicting the extent of heterogeneity in meta-Analysis, using empirical data from the cochrane database of systematic reviews. Int J Epidemiol 2012;41:818-27.
33. Rhodes KM, Turner RM, Higgins JP. Empirical evidence about inconsistency among studies in a pair-wise meta-Analysis. Res Synth Methods 2016;7:346-70.
34. Rhodes KM, Turner RM, White IR, et al. Implementing informative priors for heterogeneity in meta-Analysis using meta-regression and pseudo data. Stat Med 2016;35:5495-511.
35. Salanti G. Indirect and mixed-Treatment comparison, network, or multiple-Treatments meta-Analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods 2012;3:80-97.
36. Salanti G, Higgins JP, Ades AE, et al. Evaluation of networks of randomized trials. Stat Methods Med Res 2008;17:279-301.
37. Salanti G, Del Giovane C, Chaimani A, et al. Evaluating the quality of evidence from a network meta-Analysis. PLoS One 2014;9:e99682.
38. Dias S, Welton NJ, Caldwell DM, et al. Checking consistency in mixed treatment comparison meta-Analysis. Stat Med 2010;29:932-44.
39. Higgins JP, Jackson D, Barrett JK, et al. Consistency and inconsistency in network meta-Analysis: concepts and models for multi-Arm studies. Res Synth Methods 2012;3:98-110.
40. Veroniki AA, Vasiliadis HS, Higgins JP, et al. Evaluation of inconsistency in networks of interventions. Int J Epidemiol 2013;42:332-45.
41. Chaimani A, Salanti G. Using network meta-Analysis to evaluate the existence of small-study effects in a network of interventions. Res Synth Methods 2012;3:161-76.
42. Naeem F, Asmer MS, Khoury B, et al. Acceptance and commitment therapy for schizophrenia and related disorders. Cochrane Database Syst Rev 2015;313.
43. Gray R, Bressington D, Ivanecka A, et al. Is adherence therapy an effective adjunct treatment for patients with schizophrenia spectrum disorders? A systematic review and meta-Analysis. BMC Psychiatry 2016;16:90.
44. Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev 2000;(2):CD001089.
45. Dieterich M, Irving CB, Bergman H, et al. Intensive case management for severe mental illness. Cochrane Database Syst Rev 2017;(1):CD007906.
46. Jauhar S, McKenna PJ, Radua J, et al. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-Analysis with examination of potential bias. Br J Psychiatry 2014;204:20-9.
47. van der Gaag M, Valmaggia LR, Smit F. The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: A meta-Analysis. Schizophr Res 2014;156:30-7.
48. Hazell CM, Hayward M, Cavanagh K, et al. A systematic review and meta-Analysis of low intensity CBT for psychosis. Clin Psychol Rev 2016;45:183-92.
49. Kennedy L, Xyrichis A. Cognitive behavioral therapy compared with non-specialized therapy for alleviating the effect of auditory hallucinations in people with reoccurring schizophrenia: A systematic review and meta-Analysis. Community Ment Health J 2017;53:127-33.
50. Cella M, Preti A, Edwards C, et al. Cognitive remediation for negative symptoms of schizophrenia: A network meta-Analysis. Clin Psychol Rev 2017;52:43-51.
51. Ren J, Xia J. Dance therapy for schizophrenia. Cochrane Database Syst Rev 2013;10:CD006868.
52. Pitschel-Walz G, Leucht S, Bäuml J, et al. The effect of family interventions on relapse and rehospitalization in schizophrenia-A meta-Analysis. Schizophr Bull 2001;27:73-92.
53. Pharoah F, Mari J, Rathbone J, et al. Family intervention for schizophrenia. Cochrane Database Syst Rev 2010;12:CD000088.
54. Orfanos S, Banks C, Priebe S. Are group psychotherapeutic treatments effective for patients with schizophrenia? A systematic review and meta-Analysis. Psychother Psychosom 2015;84:241-9.
55. Roder V, Mueller DR, Mueser KT, et al. Integrated psychological therapy (IPT) for schizophrenia: is it effective? Schizophr Bull 2006;32(Suppl 1):S81-93.
56. Eichner C, Berna F. Acceptance and Efficacy of Metacognitive Training (MCT) on positive symptoms and delusions in patients with schizophrenia: A meta-Analysis taking into account important moderators. Schizophr Bull 2016;42:952-62.
57. Aust J, Bradshaw T. Mindfulness interventions for psychosis: A systematic review of the literature. J Psychiatr Ment Health Nurs 2017;24:69-83.
58. Geretsegger M, Mössler KA, Bieleninik L, et al. Music therapy for people with schizophrenia and schizophrenia-like disorders. Cochrane Database Syst Rev 2017;5:CD004025.
59. Malmberg L, Fenton M. Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness. Cochrane Database Syst Rev 2001(3):CD001360.
60. Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database Syst Rev 2000;(4):CD002831.
61. Almerie MQ, Okba Al Marhi M, Jawoosh M, et al. Social skills programmes for schizophrenia. Cochrane Database Syst Rev 2015;6:CD009006.
62. Buckley LA, Maayan N, Soares-Weiser K, et al. Supportive therapy for schizophrenia. Cochrane Database Syst Rev 2015;4:CD004716.